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Abstract
Background: For radiotherapy of the head and neck, 5-point mask immobilization is used to stabilize the
shoulders. Still, the daily position of the shoulders during treatment may be different from the position in the
treatment plan despite correct isocenter setup. The purpose of this study was to determine the interfractional
displacement of the shoulders relative to isocenter over the course of treatment and the associated dosimetric
effect of this displacement.
Methods: The extent of shoulder displacements relative to isocenter was assessed for 10 patients in 5-point
thermoplastic masks using image registration and daily CT-on-rails scans. Dosimetric effects on IMRT and VMAT
plans were evaluated in Pinnacle based on simulation CTs modified to represent shoulder shifts between 3 and 15
mm in the superior-inferior, anterior-posterior, and right-left directions. The impact of clinically observed shoulder
shifts on the low-neck dose distributions was examined.
Results: Shoulder motion was 2-5 mm in each direction on average but reached 20 mm. Superior shifts resulted in
coverage loss, whereas inferior shifts increased the dose to the brachial plexus. These findings were generally
consistent for both IMRT and VMAT plans. Over a course of observed shifts, the dose to 99% of the CTV decreased
by up to 101 cGy, and the brachial plexus dose increased by up to 72 cGy.
Conclusions: he position of the shoulder affects target coverage and critical structure dose, and may therefore be
a concern during the setup of head and neck patients, particularly those with low neck primary disease.
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Background
Patient positioning and immobilization are essential in
radiation therapy. Although extensive effort is spent in
positioning and immobilizing the patient, the focus is
on target alignment; the position of the body away from
isocenter is often ignored. Nevertheless, such distant
body positions may affect the delivered dose
distribution.
For head and neck radiotherapy or other treatments
involving the low neck, the position of the shoulders is
of particular concern. In many cases, 5-point masks that
cover the head and shoulders are used to immobilize
the patient. Still, without any displacement of isocenter,
the shoulders can be in a position different from the
one in the treatment plan. Most IMRT treatments are
delivered in a co-planar beam arrangement, so if the
patient’s shoulders move superior relative to the plan-
ning setup the shoulders could intercept the radiation
beams and cause an underdosing of the tumor. Conver-
sely, inferior shifts could increase the dose to critical
structures. This impact is of particular concern in treat-
ments that have segments near or through the
shoulders, as is often the case with intensity-modulated
radiation therapy (IMRT). The issue is also important
with volumetric modulated arc therapy (VMAT), where
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beam could routinely pass through the shoulders [1,2].
Previous studies have found shoulder displacement (in
conjunction with isocenter setup) in excess of 1 cm
[3,4]. However, these shoulder displacements were
assessed by setup images or port films, which offer only
2-dimensional information. Furthermore, although the
dosimetric impact of these shoulder shifts was specu-
lated upon, it was not quantified.
Therefore, this study sought to determine the follow-
ing: first, the extent of 3-dimensional shoulder motion
relative to treatment isocenter associated with radiother-
apy of the head and neck; second, the dosimetric effect
of shoulder position variability on IMRT and VMAT
treatments.
Materials and methods
Shoulder displacements
Daily shoulder position variation relative to treatment
isocenter was quantified using computed tomography
(CT)-based bony alignment for 10 patients with lower
neck disease involvement. These patients were diag-
nosed with cancers of the nasopharynx, oropharynx,
spine, and mouth, and were treated with 40-70 Gy to
the primary tumors with simultaneous boosts to the
nodes if needed. All of the patients were simulated and
immobilized daily with a 5-point thermoplastic mask
(Orfit Industries, Belgium) which fits over the head and
shoulders. In addition to the 5-point mask, three of the
patients were also simulated with wrist straps that
pulled the shoulders inferiorly. Two of these patients
with shoulder pulls were also treated with the straps in
place. Shoulder variation was evaluated with daily CT
scans from an in-room CT-on-rails scanner. The CT on
rails had a large field of view (50 cm), allowing both
humeral heads to be captured in the daily image.
Shoulder position variations were determined relative
to the planning image. Each humeral head and the clini-
cal bony alignment structure (the C2 vertebrae for 7
patients, C3 for 1 patient, C1-C3 for one patient, and
C7-T3 for 1 patient) were contoured on the planning
CT,. In-house image registration software [5,6] was used
to locate the humeral heads and the alignment structure
on each of the daily CTs. The results were verified
visually. To quantify shoulder motion, the centroid
coordinates for each humeral head were determined
relative to the alignment structure, yielding the daily dif-
ference in each shoulder position in each direction rela-
tive to isocenter.
To determine any trends in shoulder position with
time, a linear regression was performed on the displace-
ment versus fraction. Significance was determined by a
p-value less than 0.05 and the 95% confidence interval
not including 0.
Dosimetric impact
To investigate the dosimetric impact of shoulder shifts,
an IMRT and a SmartArc plan were developed on the
simulation CT for 3 head and neck patients using the
Pinnacle treatment planning system (Pinnacle
3 version
9, Fitchburg, WI). Patient 1 had a base of tongue tumor
treated to 60 Gy in 30 fractions with a bilateral simulta-
neous integrated boost to two nodal volumes: one to 57
Gy and another to 54 Gy, and was treated with 10
coplanar beams (200°, 240°, 280°, 320°, 0°, 40°, 80°,
120°,160°, and 180°). Patient 2 had an unknown primary
treated to 69.96 Gy in 33 fractions, with a unilateral
simultaneous integrated boost to two nodal volumes:
one to 65 Gy and one to 63 Gy, and was treated with 7
fields (350°, 20°, 55°, 85°, 120°, 150°, and 175°). Patient 3
had a laryngeal primary treated to 60 Gy in 30 fractions
with a simultaneous integrated boost to bilateral nodes
to 54 Gy, and was treated with 9 fields (200°, 240°, 280°,
320°, 0°, 40°, 80°, 120°, and 160°). The VMAT plans for
all 3 patients used two 360° arcs. The IMRT and VMAT
fields extended into the lower neck. Patients treated
with a half-beam matched technique (using AP fields to
treat the low neck) were not examined because the dose
disturbance due to shoulder variability was assumed to
be less. Per clinical practice, IMRT beams that directly
intersected the shoulders from the lateral direction had
their inferior border raised to avoid shoulder penetra-
tion (this included the 85° beam on Patient 2 only). All
plans met MD Anderson Cancer Center clinical plan-
ning objectives.
The CT images were then manually edited in Pinnacle
to simulate shoulder shifts on each patient of 3, 5, and
15 mm in the superior and inferior (SI) directions, 3
and 15 mm in the anterior and posterior (AP) direc-
tions, and 15 mm in the right or left (RL) direction.
These shifts were realized by adjusting the body and
bony contours of the shoulders. The medial areas of the
chest and back remained in the same location as the
original scans. The relative density of tissues was forced
to 1 or 0 as necessary to compensate for tissue moving
into or out of the new location (Figure 1); similarly, the
average density of each shifted bone was maintained.
The baseline plans were then recalculated on each of
these adjusted images (referred to as “shifted plans”).
This method of manual CT editing allowed for isola-
tion of specific shoulder shift sa n de x c l u d e dt h ee f f e c t s
of other anatomical differences and internal motion,
which was not available on the daily CT data. The valid-
ity of the manual CT edits was verified as follows. A
patient was identified who, on subsequent CTs (taken
on the same day), showed a 1 cm superior shift in both
shoulders and a 3.6 mm anterior shift of one shoulder.
The first CT was also edited by hand to mimic the sec-
ond CT. The dose distributions for the daily CT with
Neubauer et al. Radiation Oncology 2012, 7:19
http://www.ro-journal.com/content/7/1/19
Page 2 of 8shifted shoulders (second scan) was compared to the
dose distributions for the manually edited CT, and these
were found to be nearly identical. Therefore, the manu-
ally edited images gave a reasonable estimation of the
impact of the shoulder shifts.
Clinical impact
The dosimetric impact determined above describes the
impact of a single shift occurring every day, rather than
the dosimetric impact of a series of shifts that could be
encountered during routine clinical treatment. To assess
the clinical impact, the target coverage and critical
structure dose changes to clinical IMRT plans associated
with each shoulder shift were combined with a set of
shifts observed over the course of treatment. The cumu-
lative changes in dose to a representative point chosen
in the clinical target volume (CTV), 99% of the CTV
(D99%), and to critical structures due to shoulder varia-
tion were estimated. Specifically, for each shift in the
dosimetric studies, the change in point dose, D99%, and
maximum dose to 0.1 cm
3 of the brachial plexus per
fraction was multiplied by the number of fractions for
which each shift was observed.
Results
Observed shifts
Ten patients and 243 CTs were examined. The average
shoulder shifts observed were 2-6 mm (Table 1). Most
(85%) of the observed shifts were less than 6 mm, but 2%
of shifts were greater than 10 mm, and all patients had at
least 1 shift greater than 5 mm. Shifts greater than 10 mm
were observed in all directions except RL (Figure 2). Of
note, 4 of the 10 patients had their maximum shifts occur
in the superior direction. Some patients showed very irre-
gular shoulder positioning (Figure 3), whereas others
showed very stable positioning (Figure 4). Most patients
had a combination of random and systematic shifts; how-
ever, large shifts tended to be random. Patients with wrist
straps that pulled the shoulders inferiorly did not show
consistently smaller shifts than those treated without. For
example, the patient in Figure 3 did have shoulder pulls for
each treatment, and the patient shown in Figure 4 did not.
While it might be expected that the size of shoulder
displacements increase with time (as the patient loses
weight and the mask gets looser), this was not observed.
Regression analysis of the magnitude of the shoulder
shift over time showed that the vast majority of patients
did not demonstrate an increase in the size of the
shoulder shift with time (p > 0.05) in any of the RL, AP,
or SI directions, nor did they demonstrate an increase
in the magnitude of 3-dimensional displacement. At
most 3 patients showed a statistical increase or decrease
in magnitude of shoulder displacement in any given
direction (p < 0.05), however, these were equally
increases and decreases in magnitude.
Dosimetric impact
The target coverage losses for 2 CTV dose levels in the
neck are presented in Table 2 for shoulder shifts that
induced a loss of coverage. For both IMRT and VMAT
plans, shoulder shifts in the superior direction resulted
in the greatest loss of coverage, and the loss was com-
parable between the two modalities. Larger shifts
resulted in larger coverage losses. While 5 mm superior
shifts caused coverage losses of 2-24 cm
3 at the 100%
dose level, 15 mm superior shifts could cause coverage
losses of more than 100 cm
3 at the 100% dose level and
more than 40 cm
3 at the 95% dose level. The corre-
sponding percent loss of target coverage is shown for
patient 1 in Table 3. Target coverage losses in the 100%
isodose line were seen around C6-C7, and were between
7% and 78% of the tumor volume located at these ver-
tebral levels.
For IMRT plans (but not VMAT plans), large poster-
ior shifts also caused loss of coverage (Table 2). Cover-
age loss was seen in the C7-T2 region, and was up to
11% of the local target volume (Table 3). Shifts in other
directions (as well as smaller posterior shifts) did not
cause a change in target coverage.
Dose elevation to critical structures associated with
shoulder shifts is presented in Table 4. In general, dose
Figure 1 15 mm anterior shift. Body contours are shifted, and the
appropriate density is set.
Table 1 Range and average magnitude of shifts (cm) in
each direction for the right and left shoulder and an
average net displacment determined by the 3D-vector of
each shoulder.
RL AP SI Net
Range 0-0.85 0-1.83 0-1.96 0.10-2.01
Average (Right shoulder) 0.22 0.36 0.35 0.55
Average (Left shoulder) 0.26 0.48 0.27 0.60
Average net 0.58
AP = anterior-posterior; RL = right-left; SI = superior-inferior
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any shoulder shift considered. However, the dose to the
brachial plexus did increase, most substantially with
inferior shifts. This was seen for both IMRT and VMAT
plans, and doses could be elevated by 410 cGy for 15
mm inferior shifts. For IMRT plans (but not VMAT
plans), an increase in brachial plexus dose was also
found with anterior shifts.
Figure 2 Total distribution of shifts in all 3 directions. 85% were less than 0.6 cm. Shifts greater than 1 cm, were seen in the superior-inferior
(SI) and anterior-posterior (AP) directions. RL = right-left.
Figure 3 Shoulder displacement vs. treatment fraction. Patient with large variation in shoulder displacements over treatment. AP = anterior-
posterior; RL = right-left; SI = superior-inferior.
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When a set of observed shifts (from the patient shown
in Figure 3: one 3 mm superior, four 5 mm superior,
and seven 15 mm posterior shifts) was applied to the 3
dosimetric studies, the greatest loss of dose to 99% of
the lower neck CTV of any of the cases was a decrease
by 101 cGy (range, 14-101 cGy), with a corresponding
point dose decrease of 57-95 cGy. The largest observed
losses to 99% of the CTV per fraction (based on a 2 Gy
fraction) are outlined in Table 5. Table 5 also shows
how frequently certain shifts must occur to lose 1, 2, or
3G yt o9 9 %o ft h eC T V ;t y p i c a l l y ,l a r g en u m b e r so f
Figure 4 Shoulder displacement vs. treatment fraction. Patient with small variation in shoulder displacements over treatment. AP = anterior-
posterior; RL = right-left; SI = superior-inferior.
Table 2 Lower neck target dose changes (cm
3) due to important shifts.
Shift Patient 1 Patient 2 Patient 3
V100% V98% V95% V100% V98% V95% V100% V98% V95%
IMRT
3 mm superior Target 1 -4 0 0 -4 0 0 0 0 0
Target 2 0 0 0 -1 0 0 -1 0 0
5 mm superior Target 1 -19 -1 0 -14 -2 0 -2 0 0
Target 2 -3 0 0 -9 -1 0 -7 0 0
15 mm superior Target 1 -132 -73 -9 -53 -31 -4 -58 -20 -2
Target 2 -29 -5 -1 -64 -35 -12 -77 -25 -7
15 mm posterior Target 1 -12 0 0 -8 0 0 -4 -1 0
Target 2 -5 -1 0 -7 -2 -1 -25 -4 -1
VMAT
3 mm superior Target 1 -4 0 0 -2 -2 0 0 0 0
Target 2 -2 0 0 0 0 0 -1 0 0
5 mm superior Target 1 -24 -3 0 -7 -4 0 0 0 0
Target 2 -10 -1 0 -5 0 0 -6 -1 0
15 mm superior Target 1 -152 -102 -41 -36 -13 -1 -49 -7 0
Target 2 -43 -22 -10 -36 -11 0 -65 -29 -7
15 mm posterior Target 1 -1 0 0 -1 -1 0 0 0 0
Target 2 0 0 0 -1 -1 -1 -3 -2 -1
Target 1 = higher dose clinical target volume (CTV); target 2 = lower dose CTV; V100%, V98% and V95% are the volumes covered by the 100%, 98%, and 95%
isodose lines, respectively; 15 mm superior shifts show greatest loss of coverage for both IMRT and VMAT, and 15 mm posterior shifts show loss of coverage
greater than 4 cm
3 for IMRT plans only.
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similarly evaluated for the six 5 mm inferior and two 15
mm inferior shifts that were observed. The largest
increase in dose to 0.1 cm
3 of the brachial plexus of all
of the examined dosimetric cases was 72 cGy (range,
64-72 cGy).
Discussion
T h i ss t u d yf o u n dt h a tl a r g es h i f t s( >1c m )r o u t i n e l y
occurred during the course of radiotherapy, even when
5-point masks are used. In general, there was no trend
with time in the magnitude of shifts in the RL, AP, or
SI directions. Although some patients did show either
an increasing or decreasing trend in the size of shoulder
shift as treatment progressed, equal numbers of patients
had shifts that were larger or smaller and the vast
majority had no trend in any direction. While large
shoulder shifts could be expected to occur late in treat-
ment due to patient relaxation or weight loss, we
observed such shifts to occur equally both early and late
in treatment.
In this study, we observed the largest shoulder shifts
in the AP and SI directions, which is different from
results reported in the literature where the largest shifts
were found in the RL direction. However, our study
examined the position after correct isocenter setup,
whereas the others examined the position prior to cor-
rect setup [3,4] and evaluated how much the shoulders
or the shoulder region had to be moved to properly
align isocenter. These studies were also limited by visibi-
lity on megavoltage images. However, the magnitudes of
the shoulder displacements were comparable between
our study and the others, being typically less than 6
mm.
The observed shoulder motion is consistent with pre-
vious studies that showed lower-neck structures experi-
ence more setup variability when aligning to C2 [7,8]. If
the patient were setup using a lower target for align-
m e n t ,s u c ha sC 7 ,t h e r em a yb ear e d u c t i o ni nt h es i z e
of the observed shoulder shift as medial lower-neck tar-
gets would show less variability. However, this was not
observed in this study. Only one patient was aligned to
vertebral bodies in the low neck (C7-T3) and this
patient showed a great deal of shoulder variability (Fig-
ure 3). The authors believe that the shoulders may still
show large displacements because the shoulders are far
from mid-line and can move independently of the low
neck vertebral bodies, and are often ignored in setup.
One drawback to our method of aligning the patient is
that is only occurs in the 3 linear directions without any
rotational component. Therefore, it was not possible to
reduce or minimize shoulder shifts that were the result
of rotated anatomy. Therefore, the size of observed
shoulder shifts may be reduced if the IGRT process
includes rotational as well as translational shifts. How-
ever, based on the findings throughout this work that
the shoulders move largely independently, it is likely
that large shoulder displacements could still occur, even
with rotation accounted for.
The greatest change in lower neck target coverage was
found for superior shifts because these brought shoulder
tissue into a region where it was previously absent,
thereby changing the depth and beam attenuation to the
target. This was observed even when the inferior jaws of
lateral fields are closed above the shoulder, as seen in
Patient 2 (Table 2). A similar result was found for large
posterior shifts, which resulted in target coverage loss
Table 4 Brachial plexus dose change (cm
3) due to
important shifts.
Patient 1 Patient 2 Patient 3
Shift IMRT VMAT IMRT VMAT IMRT VMAT
3 mm inferior
Max DVH dose (cGy) -1 -3 116 12 45 -29
Max 0.1 cm
3 (cGy) 0 40 100 45 40 60
V60 (cm
3) 000000
15 mm inferior
Max DVH dose (cGy) 49 372 203 186 218 259
Max 0.1 cm
3 (cGy) 60 410 205 195 210 240
V60 (cm
3) 130001
3 mm anterior
Max DVH dose (cGy) -1 0 22 1 23 -14
Max 0.1 cm
3 (cGy) 0 0 15 5 20 -20
V60 (cm
3) 000000
15 mm anterior
Max DVH dose (cGy) -1 1 125 10 109 -64
Max 0.1 cm
3 (cGy) 0 0 100 0 100 -70
V60 (cm
3) 000000
The changes in maximum dose displayed on the dose volume histogram
(DVH), maximum dose to 0.1 cm
3, and volume receiving 60 Gy (V60) are
shown. Inferior shifts show the greatest increase in dose to the brachial
plexus for both intensity-modulated radiation therapy (IMRT) and volumetric
modulated arc therapy (VMAT) plans.
Table 3 Target coverage in the C6-C7 region
IMRT VMAT
100% 98% 95% 100% 98% 95%
C6-C7
No shift 97 98 100 94 97 99
5 mm superior 90 98 100 84 96 99
15 mm superior 23 53 94 16 35 72
C7-T2
No shift 98 100 100 –– –
15 mm posterior 89 99 100 –– –
Percentage of the clinical target volume (CTV) in the C6-C7 region covered by
the 100%, 98%, and 95% isodose lines with no shift and with superior shifts
for IMRT and VMAT plans, as well as the percent coverage of the CTV in the
C7-T2 region with no shift and a 15 mm posterior shift. All percentages were
evaluated for Patient 1.
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loss of coverage for posterior shifts. This likely resulted
from the Monitor Unit (MU) distribution; even though
beams were evenly spaced around the patient, the IMRT
plans had ~50% of the MU from posterior or posterior
oblique beams. In contrast, VMAT plans had a relatively
even distribution of MUs with gantry angle.
It is important to note thatt h ec o v e r a g el o s sf r o m
superior and posterior shifts was not compensated for
by an equivalent increase in coverage from inferior or
anterior shifts. That is, the effect of the shift does not
average out over the course of treatment. This can be
understood by considering that a superior shift will
cause attenuation and loss of coverage to a transverse
section of the neck. A subsequent inferior shift will
increase the dose slightly, but to a different transverse
section of the neck (an inferior section), thereby not
compensating for the dose loss associated with the
superior shift. The position of the shoulder each day has
an impact on coverage, and a mean shoulder position
will not represent the total effect of the shoulder move-
ment over the course of treatment. Documentation of
the number of superior and large posterior shifts will
give the best information about loss of coverage to the
target.
In a clinical setting, the most important impact of
shoulder motion is the loss of target coverage (~1 Gy to
99% of a lower neck target). This may be important,
particularly if there is primary disease in that region.
Moreover, shoulder shifts may be an important consid-
eration for Stereotactic Spine Radiosurgery (SSRS) or for
other patients undergoing hypofractionated therapy with
lesions near C6. These IMRT plans are delivered in few
(or one) fractions, so large errors are not mitigated by
subsequent fractions. It is important to consider that
this positioning study found no trend with time for
large shoulder shifts; large shifts (> 1 cm) were seen in
the first few days of treatment for many patients. In
addition to these considerations, treatments that use
predominantly posterior beams may suffer coverage loss
worse than that predicted in this study. Also, systematic
shoulder shifts are more likely to cause substantial dose
losses similar to those shown in Table 2. While most
patients in this study had small systematic shifts, 2
patients demonstrated large (8-10 mm) systematic shifts.
When we evaluated dosimetric impact, no clinically
important change was seen in dose to the spinal cord
because it had been avoided in the treatment plans and
it was always associated with low photon fluences. How-
ever, the brachial plexus was located close to the targets,
so changes in shoulder position affected beam attenua-
tion and dose to this structure. The overall 72 cGy
increase in dose to 0.1 cm
3 of the brachial plexus is not
likely to cause harm because the max dose to 0.1 cm
3 of
t h eb r a c h i a lp l e x u si sn o ta l w a y si nt h es a m el o c a t i o n
within the structure, depending on shoulder position.
The daily increase in dose to 0.1 cm
3 of the brachial
plexus was a few cGy; therefore, the dose escalation
required to receive a TD5/5 dose of over 60 Gy [9] on a
single day was not observed.
Conclusions
In general, shoulder positional variation is approximately
2-6 mm; however, large shifts up to 2 cm may be possi-
ble even when 5-point masks that extend over the
shoulders are used. Large superior shifts can lead to
underdosing of lower neck targets if they occur fre-
quently. No trend was seen for large shifts with time, so
patients are at risk for having large shoulder displace-
ments early and late in treatment. Because up to 1 Gy
can be lost from shoulder variation over the course of
treatment, including shoulder position in daily setup
procedures would be beneficial to head and neck
patients with low neck targets. The dose-coverage losses
demonstrated in this study may underestimate losses
that occur for hypofractionated or single fraction treat-
ments; therefore, the position of the shoulder warrants
particular attention in these instances. If they can be
captured in the field of view, proper shoulder alignment
can be discerned from daily imaging and compared to
Digitally Reconstructed Radiographs (DRR). The angle
of the clavicle in an AP image can also indicate a super-
ior shoulder shift if it is steeper than it appears in a
DRR. If possible, the shoulders or humeral heads can
Table 5 Dose loss due to shoulder shifts
Frequency for losses of:
Shift Dose lost per fraction (cGy) 1 Gy 2 Gy 3 Gy
5 mm superior -3 33 ––
15 mm superior -11 9 18 27
15 mm posterior -5 20 ––
5 mm superior + 15 mm posterior -8 13 25 –
15 mm superior + 15 mm posterior -16 6 13 19
Dose lost to 99% of the clinical target volume due to superior and posterior shifts and the number of shifts required for a D99% loss of 1, 2, or 3 Gy. Dashes
represent > 35 fractions required.
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Beam CT setup. If imaging data is not available due to
field of view limitations, indexing the position of
shoulders to the treatment couch via mask marks
should at least help to avoid superior shifts.
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